+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07456280

Evaluating a Noninvasive Heart Monitoring Device for Early Hospital Discharge After TAVI in Patients with Conduction Disorders

Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2026-07-22

100

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the effectiveness and safety of a non-invasive electrocardiographic monitoring strategy combined with early discharge in patients who have conduction disorders following transfemoral or transaortic transcatheter aortic valve implantation TAVI for severe aortic stenosis. The study compares this approach to standard care to understand its potential benefits. Patients included have specific conduction disorders and are clinically stable 24 hours after the TAVI procedure. Participants are randomly assigned to one of two groups. One group is discharged from the hospital 24 hours after TAVI with the PhysioMem PM 100 4G ambulatory monitoring device to track heart conduction remotely. The other group follows the usual discharge procedures under standard care. The study measures outcomes over 30 days and up to 12 months, including death rates, rehospitalizations, heart rhythm events, and quality of life. During the study, participants undergo monitoring of heart rhythm events and clinical status, including remote electrocardiographic assessments. The research team tracks events such as arrhythmias requiring therapy changes, pacemaker implantation, and hospital readmissions. Quality of life is assessed with questionnaires, and data on hospital stay lengths and costs are collected. The total study participation lasts up to 12 months with follow-up evaluations to observe both short- and long-term effects.

CONDITIONS

Brief Title

Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)

Research Team

B

Bruno García del Blanco, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here